tiprankstipranks
Lexaria Bioscience (LEXX)
NASDAQ:LEXX
US Market
LEXX
Lexaria Bioscience
RESEARCH TOOLSreports
Want to see LEXX full AI Analyst Report?

Lexaria Bioscience (LEXX) Income Statement

245 Followers

Lexaria Bioscience Income Statement

Last quarter (Q2 2026), Lexaria Bioscience's total revenue was $20.00K, a decrease of -88.51% from the same quarter last year. In Q2, Lexaria Bioscience's net income was $-1.45M. See Lexaria Bioscience’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Aug 25Aug 24Aug 23Aug 22Aug 21
Total Revenue
$ 705.92K$ 464.28K$ 226.21K$ 255.40K$ 722.74K
Gross Profit
$ 587.35K$ 383.30K$ 53.96K$ 46.71K$ 547.39K
Operating Expenses
$ 12.22M$ 6.08M$ 6.59M$ 6.55M$ 6.07M
Depreciation and Amortization
$ 115.85K$ 76.15K$ 145.40K$ 146.91K$ 147.60K
EBITDA
$ -11.80M$ -5.73M$ -6.57M$ -7.24M$ -4.02M
Operating Income
$ -11.63M$ -5.70M$ -6.53M$ -6.50M$ -5.52M
Other Income/Expenses
$ -278.06K$ -113.36K$ -178.50K$ -882.81K$ 1.36M
Pretax Income
$ -11.91M$ -5.81M$ -6.71M$ -7.38M$ -4.16M
Net Income
$ -11.90M$ -5.80M$ -6.66M$ -7.27M$ -4.03M
Per Share Metrics
Basic EPS
$ -0.66$ -0.47$ -1.01$ -1.24$ -0.92
Diluted EPS
$ -0.66$ -0.47$ -1.01$ -1.24$ -0.92
Weighted Average Shares Outstanding
 18.00M 12.38M 6.61M 5.89M 4.39M
Weighted Average Shares Outstanding (Diluted)
 18.00M 12.38M 6.61M 5.89M 4.39M
Currency in USD

Lexaria Bioscience Earnings and Revenue History